[3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3- methylphenyl) acetamide): An agonist radioligand selective for the dopamine D4 receptor

European Journal of Pharmacology

Volumn 497, Issue 2, 2004, Pages 147-154

  Moreland, Robert B ^a   Terranova, Marc A ^a   Chang, Renjie ^a   Uchic, Marie E ^a   Matulenko, Mark A ^a   Surber, Bruce W ^a   Stewart, Andrew O ^a   Brioni, Jorge D ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

A 369508; Dopamine; Spiperone

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 [4 (2 CYANOPHENYL) 1 PIPERAZINYL] N (3 METHYLPHENYL)ACETAMIDE; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 5 FLUORO 2 (4 PYRIDIN 2 YLPIPERAZIN 1 YLMETHYL) 1H INDOLE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; A 369508; ACETAMIDE DERIVATIVE; APOMORPHINE; BENZAMIDE DERIVATIVE; CLOZAPINE; CP 226269; CYANOPINDOLOL; CYCLIC AMP; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FORSKOLIN; HALOPERIDOL; INDOLE DERIVATIVE; N [4 (2 CYANOPHENYL)PIPERAZIN 1 YLMETHYL] 3 METHYLBENZAMIDE; PD 168077; PRAZOSIN; SPIPERONE; UNCLASSIFIED DRUG; 2 (4 (2 CYANOPHENYL) 1 PIPERAZINYL) N (3 METHYLPHENYL) ACETAMIDE; 2-(4-(2-CYANOPHENYL)-1-PIPERAZINYL)-N-(3-METHYLPHENYL) ACETAMIDE; DOPAMINE 2 RECEPTOR; DRD4 PROTEIN, HUMAN; DRD4 PROTEIN, RAT; LIGAND; PIPERAZINE DERIVATIVE; TRITIUM;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BRAIN CORTEX; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CHO CELL; CONTROLLED STUDY; CORPUS STRIATUM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; EMBRYO; HIPPOCAMPUS; HUMAN; HUMAN CELL; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIOASSAY; RAT; STRUCTURE ACTIVITY RELATION; ANIMAL; CELL LINE; CHEMISTRY; DOSE RESPONSE; DRUG POTENTIATION; HAMSTER; METABOLISM; METHODOLOGY;

ACETAMIDES; ANIMALS; CELL LINE; CHO CELLS; CRICETINAE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIGANDS; PIPERAZINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; TRITIUM;

EID: 4143106971     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.06.049     Document Type: Article

References (25)

1. M.A. Ariano, J. Wang, K.L. Noblett, E.R. Larson, and D.R. Sibley Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera Brain Res. 752 1997 26 34
2. 4 receptor variants J. Neurochem. 65 1995 1157 1165
3. 4 receptors by ABT-724 facilitates penile erection in rats Proc. Natl. Acad. Sci. U. S. A. 101 2004 6758 6763
4. 2. Program No. 830.9. Soc. Neurosci. Abstr. 28: 830.9.
5. 50) of an enzymatic reaction Biochem. Pharmacol. 22 1973 3099 3108
6. 4 receptor in the mouse brain J. Neurosci. Res. 59 2000 202 208
7. J. De Vry, R. Schohe-Loop, H.G. Heine, J.M. Greuel, F. Mauler, B. Schmidt, H. Sommermeyer, and T. Glaser Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5- hydroxytryptamine1A receptor agonist J. Pharmacol. Exp. Ther. 284 1998 1082 1094
8. 4 receptor Naunyn-Schmiedeberg's Arch. Pharmacol. 361 2000 555 564
9. 4 agonists J. Med. Chem. 40 1997 1771 1772
10. 4 receptor: a controversial therapeutic target Drugs Future 25 2000 587 611
11. G.C. Hsieh, P.R. Hollingsworth, B. Martino, R. Chang, M.A. Terranova, A.B. O'Neill, J.J. Lynch, R.B. Moreland, D.L. Donnelly-Roberts, T. Kolasa, J. Mikusa, J.M. McVey, K.C. Marsh, J.P. Sullivan, and J.D. Brioni Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the pro-erectile effect of apomorphine J. Pharmacol. Exp. Ther. 308 2004 330 338
12. T. Kenakin Drug efficacy at G protein-coupled receptors Annu. Rev. Pharmacol. Toxicol. 42 2002 349 379
13. 2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain J. Comp. Neurol. 402 1998 353 371
14. 4 receptor-selective ligands Eur. J. Pharmacol. 367 1999 139 142
15. 2 guanine nucleotide-binding protein-coupled receptor: utilization of receptor state binding affinities Mol. Pharmacol. 42 1992 432 438
16. 4 receptor agonist and radioligand Biorg. Med. Chem. Lett 2004 (in press)
17. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron Dopamine receptors: from structure to function Physiol. Rev. 78 1998 189 225
18. R.B. Moreland, M. Nakane, G. Hsieh, and J. Brioni The biochemical and neurologic basis for treatment of male erectile dysfunction J. Pharm. Exp. Ther. 296 2 2001 225 234
19. qo5 Biochem. Pharmacol. 68 2004 761 772
20. 4 receptor: one decade of research Eur. J. Pharmacol. 405 2000 303 327
21. 4 receptors: significance for molecular psychiatry at the millennium Mol. Psychiatry 4 1999 529 538
22. 4 receptors in rat forebrain Int. J. Dev. Neurosci. 18 2000 29 37
23. 4 receptors of 2-aminotetralins. Relevance of D2 agonist binding for determination of receptor subtype selectivity J. Med. Chem. 39 1996 4233 4237
24. L.T. Williams, and R.J. Lefkowitz Slowly reversible binding of catecholamine to a nucleotide-sensitive state of the beta-adrenergic receptor J. Biol. Chem. 252 1977 7207 7213
25. 4 agonist Soc. Neurosci. Abstr. 23 1997 685